HRS-4357 injection

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Advanced Prostate CancerPSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Phase 1

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

Jiangsu HengRui Medicine Co., Ltd.Advanced Prostate Cancer

Start: 2023-09-30End: 2024-10-31Target: 49Updated: 2023-08-23

Phase 3

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

RecruitingNCT07311694

Jiangsu HengRui Medicine Co., Ltd.PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Start: 2026-02-02End: 2028-12-01Target: 370Updated: 2026-02-04